CMS summary of Q1 2024 HCPCS Level II update includes 48 new codes

Why This Topic Matters

Quarterly HCPCS Level II updates can affect charge capture, claims processing, and code maintenance workflows. This article helps readers identify that CMS has released new, revised, and discontinued entries affecting drug and biological reporting for the quarter.

Article Sections

1. Q1 2024 HCPCS Level II update summary

   Overview of CMS’s first-quarter 2024 HCPCS Level II application decisions, including the types of changes reported and the general categories of products involved.

2. Examples of new HCPCS Level II codes

   Selected newly added HCPCS Level II identifiers discussed in the CMS summary, with emphasis on drug and product categories covered by the update.

3. Codes scheduled for discontinuation

   HCPCS Level II identifiers identified in the summary as being discontinued, along with the timing of those changes.

4. Revised HCPCS Level II codes

   Existing HCPCS Level II identifiers that CMS lists as having definition revisions in this update cycle.

5. Resource

   Reference to the CMS source document supporting the quarterly HCPCS Level II update summary.